… McCuskey R, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatic microvascular
dysfunction during evolution of dietary steatohepatitis in mice. HEPATOLOGY 2004;40:386…

Fatty liver (steatosis) is highly prevalent in China and is more often linked to obesity than to
alcoholism. Among more affluent regions of China, the community prevalence of non-…

The definable causes of nonalcoholic steatohepatitis (NASH) include jejunoileal bypass
surgery (JIB), other causes of rapid and profound weight loss in obese subjects, total parenteral …

Patients with nonalcoholic fatty liver disease (NAFLD) and advanced liver fibrosis are at the
highest risk for progressing to end‐stage liver disease. We constructed and validated a …

Nonalcoholic steatohepatitis (NASH) is often linked with disorders that are clearly associated
with insulin resistance (IR): obesity, type 2 diabetes mellitus, and hypertriglyceridemia. We …

… Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-…
Hui JM, Farrell GC. Clear messages from sonographic shadows? Links between metabolic …

Background & Aims : Chronic hepatitis C virus infection is associated with an increased
prevalence of type 2 diabetes. We hypothesized that virus-induced insulin resistance may be a …

Nonalcoholic steatohepatitis (NASH) and alcoholic liver disease have similar pathological
features. Because CYP2E1 plays a key role in alcoholic liver disease with its ability to …

Background & Aims NOD-like receptor protein 3 (NLRP3) inflammasome activation occurs in
Non-alcoholic fatty liver disease (NAFLD). We used the first small molecule NLRP3 inhibitor…

… George J, Murray M, Byth K, Farrell GC. Differential alterations of cytochrome P450
proteins in livers from patients with severe chronic liver disease. HEPATOLOGY 1995;21:120-128. …